DA
DGX icon

Denali Advisors’s Quest Diagnostics DGX Stock Holding History

Denali Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-300
Closed -$39.9K – 253
2024
Q1 		$39.9K Sell
300
-2,403
-89% -$312K 0.01% 291
2023
Q4 		$373K Sell
2,703
-302
-10% -$39.7K 0.11% 177
2023
Q3 		$366K Sell
3,005
-1,302
-30% -$173K 0.13% 171
2023
Q2 		$605K Sell
4,307
-1
-0% -$138 0.21% 124
2023
Q1 		$609K Sell
4,308
-92
-2% -$13.2K 0.25% 98
2022
Q4 		$688K Buy
+4,400
New +$632K 0.29% 83
2021
Q1 		– Sell
-15,400
Closed -$1.83M – 383
2020
Q4 		$1.83M Hold
15,400
– – 0.31% 107
2020
Q3 		$1.76M Hold
15,400
– – 0.35% 96
2020
Q2 		$1.75M Sell
15,400
-5,000
-25% -$530K 0.34% 98
2020
Q1 		$1.64M Buy
20,400
+1,300
+7% +$135K 0.36% 74
2019
Q4 		$2.04M Buy
19,100
+13,000
+213% +$1.36M 0.29% 104
2019
Q3 		$653K Buy
+6,100
New +$626K 0.09% 175
2019
Q2 		– Sell
-1,900
Closed -$171K – 305
2019
Q1 		$171K Hold
1,900
– – 0.03% 151
2018
Q4 		$158K Sell
1,900
-56,544
-97% -$5.3M 0.03% 111
2018
Q3 		$6.31M Sell
58,444
-42,800
-42% -$4.69M 0.93% 40
2018
Q2 		$11.1M Buy
101,244
+8,400
+9% +$875K 1.67% 26
2018
Q1 		$9.31M Buy
92,844
+1,200
+1% +$123K 1.49% 31
2017
Q4 		$9.03M Buy
91,644
+5,173
+6% +$490K 1.4% 33
2017
Q3 		$8.1M Buy
86,471
+7,200
+9% +$764K 1.34% 32
2017
Q2 		$8.81M Buy
79,271
+13,700
+21% +$1.45M 1.44% 32
2017
Q1 		$6.44M Sell
65,571
-987
-1% -$94.1K 0.95% 40
2016
Q4 		$6.12M Sell
66,558
-62,600
-48% -$5.4M 1.06% 41
2016
Q3 		$10.9M Buy
129,158
+16,058
+14% +$1.35M 1.66% 18
2016
Q2 		$9.21M Buy
113,100
+54,900
+94% +$4.18M 1.59% 22
2016
Q1 		$4.16M Buy
58,200
+5,700
+11% +$382K 0.91% 41
2015
Q4 		$3.73M Buy
52,500
+51,800
+7,400% +$3.48M 0.84% 43
2015
Q3 		$43K Buy
+700
New +$48.9K 0.01% 138

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Denali Advisors's DGX Position: Q2 2024 in Review

Denali Advisors sold out of Quest Diagnostics (DGX) in Q2 2024, closing a stake of 300 shares — an estimated $39.9K sold.

Denali Advisors first reported a position in DGX in Q3 2015 and held it in 27 quarters. The position peaked at $11.1M in Q2 2018. 837 funds tracked by Wall St. Rank hold DGX as of Q2 2024.

  • Denali Advisors reported no remaining Quest Diagnostics position as of Q2 2024 after selling out during the quarter.
  • Denali Advisors sold 300 Quest Diagnostics shares in Q2 2024, an estimated $39.9K.
  • Denali Advisors first reported a position in Quest Diagnostics in Q3 2015 and held it in 27 quarters.
  • Denali Advisors's Quest Diagnostics position peaked at $11.1M in Q2 2018.
  • 837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2024.

Based on Denali Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.